MetLife Investment Management’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $250K | Sell |
12,579
-276
| -2% | -$5.49K | ﹤0.01% | 2068 |
|
|
2025
Q1 | $217K | Hold |
12,855
| – | – | ﹤0.01% | 2155 |
|
|
2024
Q4 | $237K | Hold |
12,855
| – | – | ﹤0.01% | 2213 |
|
|
2024
Q3 | $279K | Hold |
12,855
| – | – | ﹤0.01% | 2108 |
|
|
2024
Q2 | $252K | Buy |
12,855
+1,099
| +9% | +$21.6K | ﹤0.01% | 2103 |
|
|
2024
Q1 | $255K | Hold |
11,756
| – | – | ﹤0.01% | 2059 |
|
|
2023
Q4 | $340K | Hold |
11,756
| – | – | ﹤0.01% | 1917 |
|
|
2023
Q3 | $314K | Hold |
11,756
| – | – | ﹤0.01% | 1917 |
|
|
2023
Q2 | $435K | Hold |
11,756
| – | – | ﹤0.01% | 1788 |
|
|
2023
Q1 | $367K | Hold |
11,756
| – | – | ﹤0.01% | 1845 |
|
|
2022
Q4 | $350K | Hold |
11,756
| – | – | ﹤0.01% | 1870 |
|
|
2022
Q3 | $448K | Hold |
11,756
| – | – | ﹤0.01% | 1721 |
|
|
2022
Q2 | $641K | Hold |
11,756
| – | – | 0.01% | 1491 |
|
|
2022
Q1 | $734K | Buy |
11,756
+4,339
| +59% | +$271K | ﹤0.01% | 1530 |
|
|
2021
Q4 | $746K | Hold |
7,417
| – | – | 0.01% | 1273 |
|
|
2021
Q3 | $667K | Hold |
7,417
| – | – | 0.01% | 1362 |
|
|
2021
Q2 | $684K | Buy |
7,417
+2,364
| +47% | +$218K | 0.01% | 1392 |
|
|
2021
Q1 | $488K | Hold |
5,053
| – | – | ﹤0.01% | 1536 |
|
|
2020
Q4 | $263K | Hold |
5,053
| – | – | ﹤0.01% | 1832 |
|
|
2020
Q3 | $202K | Buy |
+5,053
| New | +$202K | ﹤0.01% | 1859 |
|